Cardiac resynchronization device

A cardiac resynchronization device is a type of artificial pacemaker with leads placed at several sites in the heart. The MeSH scope note says such devices treat conduction disturbances that interfere with the timing of contraction of the ventricles, and that they may or may not include defibrillating electrodes. FDA lists three types as class 3 devices: CRT pacemakers (product code NKE), CRT defibrillators (NIK) and leadless CRT (SEG). The classification definitions name patients who have moderate to severe heart failure. One 2005 FDA approval supplement for a family of CRT pacemakers (P030035, supplement S003, approved 29 April 2005) states indications in heart failure and is quoted as an example; the original approval, other supplements and current labeling were not read. This page records no study of benefit or harm.

Also called CRT device · CRT-P · CRT-D · Biventricular pacemaker

  • Technology
  • In this atlas

Overview

Technical summary

MeSH descriptor D058409 (Cardiac Resynchronization Therapy Devices) is an exact match; its broader descriptor is D010138 (Pacemaker, Artificial), the exact match of the pacemaker page. FDA product codes NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)), NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)) and SEG (Leadless Cardiac Resynchronization Therapy (Crt)), each class 3 in the openFDA classification records read 2026-11-18, are broad matches: each names one type of device. The approval facts are for one device family, the Frontier and Frontier II pacemakers (premarket approval P030035; supplement S003, decision 2005-04-29, product code NKE). The procedure has its own page.

How it works

An artificial pacemaker with leads at multiple sites in the heart, used for conduction disturbances that interfere with the timing of contraction of the ventricles; some include defibrillating electrodes (MeSH scope note).

Classification codes

  • FDA product code openFDA device classification endpoint, retrieved 2026-11-18 NKE Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)
  • FDA product code openFDA device classification endpoint, retrieved 2026-11-18 NIK Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
  • FDA product code openFDA device classification endpoint, retrieved 2026-11-18 SEG Leadless Cardiac Resynchronization Therapy (Crt)

Limitations

  • The sources read are three FDA classification records, one 2005 approval supplement for one pacemaker family and a MeSH scope note; they state definitions and indications, and no study result is recorded on this page.
  • The approval facts cover one device family only.

Required infrastructure

  • The MeSH scope note describes implantable leads placed at multiple intracardial sites.

Claims and evidence

Context Cardiac resynchronization devices as classified by the US FDA under product codes NKE, NIK and SEG

Recipient
No clinical recipient
Population
Not applicable: the classification records describe device types, not a patient group, although the NKE and NIK definitions name patients who have moderate to severe heart failure.
Care setting
Not stated in the classification records
Geography
United States (FDA device classification record)
Life stage
Not applicable
Follow-up
Not applicable (regulatory classification)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
Included
None stated
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The openFDA device classification names three product codes for cardiac resynchronization devices, each in class 3: NKE, a pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P); NIK, an automatic implantable cardioverter defibrillator with cardiac resynchronization (CRT-D); and SEG, leadless cardiac resynchronization therapy. The NKE definition says the devices are indicated for patients who have moderate to severe heart failure and use an additional lead to provide synchronized pacing. The NIK definition says the devices will be indicated for patients needing an ICD who also have moderate to severe heart failure and are indicated for cardiac resynchronization therapy. The SEG definition says the therapy is intended to deliver CRT using a leadless left ventricular implant.

    Applies to No clinical recipient Cardiac resynchronization devices as classified by the US FDA under product codes NKE, NIK and SEG

    Certainty method
    Not assessed
    Limitations
    A regulatory classification, not a finding about benefit or safety. The definitions are brief and give no clinical criteria for use. The NIK definition is written in the future tense (will be indicated); it is quoted as FDA wrote it. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (14)
    1. Supports openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09. · FDA product code: NKE

      Locator
      results[0].product_code
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    2. Supports openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09. · FDA product code: NKE

      Locator
      results[0].device_name
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    3. Supports openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09. · FDA product code: NKE

      Locator
      results[0].device_class
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    4. Supports openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09. · FDA product code: NIK

      Locator
      results[0].product_code
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    5. Supports openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09. · FDA product code: NIK

      Locator
      results[0].device_name
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    6. Supports openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09. · FDA product code: NIK

      Locator
      results[0].device_class
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    7. Supports openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09. · FDA product code: SEG

      Locator
      results[0].product_code
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    8. Supports openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09. · FDA product code: SEG

      Locator
      results[0].device_name
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    9. Supports openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09. · FDA product code: SEG

      Locator
      results[0].device_class
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    10. Supports openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09. · FDA product code: NKE

      Locator
      results[0].definition, sentence 1
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    11. Supports openFDA device classification, product code NKE (Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (CRT-P))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NKE, from a dataset last updated 2026-11-09. · FDA product code: NKE

      Locator
      results[0].definition, sentence 2
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      621c6689ca31f2c093c2059ee6cd6eb0f7f614d926f78911def537ef1534c4dd
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    12. Supports openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09. · FDA product code: NIK

      Locator
      results[0].definition, fragment 1 of 2
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    13. Supports openFDA device classification, product code NIK (Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (CRT-D))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code NIK, from a dataset last updated 2026-11-09. · FDA product code: NIK

      Locator
      results[0].definition, fragment 2 of 2
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      c003f4ded9970117a0bef6cffd8b1e3e8aa3d511e5e858f37e059cd71552c458
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.
    14. Supports openFDA device classification, product code SEG (Leadless Cardiac Resynchronization Therapy (CRT))

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA device classification record returned on 2026-11-18 for product code SEG, from a dataset last updated 2026-11-09. · FDA product code: SEG

      Locator
      results[0].definition
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2026-11-09
      Source state
      Current
      Version fingerprint
      25adb35b50268fc3935d064bb7f62a9ede9bc785defacc0d3c636f536402e3ae
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository.

Context Patients for whom the 2005 US approval order for the Frontier cardiac resynchronization pacemakers states an indication: heart failure

Recipient
Recipient not specified
Population
Patients with heart failure as the order words it: two groups, described in the order's own terms (NYHA class, ejection fraction, QRS duration, AV nodal ablation). The statement read does not name an age group.
Care setting
Implanted cardiac resynchronization pacemaker
Geography
United States (FDA premarket approval supplement record)
Life stage
Not stated in the statement read
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (regulatory statement)
Eligibility: 2 inclusion criteria; exclusion criteria not stated
Included
  • Patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA class II or III heart failure
  • Patients with moderate to severe heart failure (NYHA class III or IV) who remain symptomatic despite stable, optimal medical therapy and have an ejection fraction in the left ventricle of 35% or less and a prolonged QRS duration
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The openFDA record of premarket approval supplement S003 to P030035 (applicant Abbott Medical, decision APPR, 29 April 2005, product code NKE) is for the Frontier Model 5508L and Frontier II Model 5586 cardiac resynchronization therapy pacemakers. The order says the devices are indicated for maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA class II or III heart failure, and for reducing the symptoms of moderate to severe heart failure (NYHA class III or IV) in patients who remain symptomatic despite stable, optimal medical therapy and have an ejection fraction in the left ventricle of 35% or less and a prolonged QRS duration.

    Applies to Recipient not specified Patients for whom the 2005 US approval order for the Frontier cardiac resynchronization pacemakers states an indication: heart failure

    Certainty method
    Not assessed
    Limitations
    This claim covers one supplement (S003, 2005) for one pacemaker family. P030035 has other supplements, and other cardiac resynchronization devices have their own approvals; none of them was read for this page, and current labeling was not read. An FDA approval is a decision about a device, not a finding about how well it works. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (12)
    1. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].pma_number
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    2. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].supplement_number
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    3. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].applicant
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    4. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].trade_name
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    5. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].decision_date
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    6. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].decision_code
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    7. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].product_code
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    8. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].ao_statement, fragment 1 of 5
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    9. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].ao_statement, fragment 2 of 5
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    10. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].ao_statement, fragment 3 of 5
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    11. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].ao_statement, fragment 4 of 5
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.
    12. Supports FDA premarket approval P030035, supplement S003: Frontier and Frontier II cardiac resynchronization therapy pacemakers (openFDA record)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of supplement S003 to P030035 (decision date 2005-04-29), returned on 2026-11-18, dataset last updated 2026-11-09. Only this one supplement record is read; P030035 has other supplement records in openFDA. · PMA: P030035

      Locator
      results[0].ao_statement, fragment 5 of 5
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2005-04-29
      Source state
      Current
      Version fingerprint
      16a58bef19723111b7395a0fc01b901bd71309c4c8703c2ec0dd5c53aa0d421c
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (https://open.fda.gov/license/, fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only; byte-identical to the copy fetched 2026-11-08). The raw record is committed in the atlas repository. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Record details

Record id
cardio:cardiac-resynchronization-device
Content hash
1413918383b24f5b1fd6cac6baf51f5e7a84e7bfa272482cf30a914137658c57